-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Persistent reflux after laparoscopic sleeve gastrectomy can be frustrating for both patients and clinicians. Heartburn, regurgitation, chest discomfort, cough and disturbed sleep may continue even when a patient is taking acid-suppressing medicine correctly. Symptoms can also change after surgery as the stomach’s shape, pressure and emptying patterns alter.
Refractory gastro-oesophageal reflux disease (GERD) generally means troublesome symptoms or objective reflux that continues after an appropriate trial of treatment. It is important to confirm that reflux is the cause before escalating therapy. Functional dyspepsia, gallbladder disease, oesophageal sensitivity, medication effects and complications of the sleeve can produce similar complaints.
In Australia, assessment may begin with a general practitioner and continue through a private bariatric service, public hospital clinic or gastroenterology practice. Access, Medicare arrangements, private health insurance and waiting times vary between metropolitan centres such as Sydney, Melbourne, Brisbane and Perth and regional areas. A structured pathway helps avoid repeated medication changes without identifying the underlying problem.
Sleeve gastrectomy creates a narrow, high-pressure gastric tube. The operation may reduce the stomach’s ability to accommodate food and can affect the angle between the oesophagus and stomach. A disrupted or weakened lower oesophageal sphincter, an enlarged sleeve, twisting, narrowing or an untreated hiatus hernia may allow gastric contents to move upwards.
Weight loss can improve reflux for some people, but postoperative anatomy may create new symptoms in others. Rapid eating, large meals, carbonated drinks and lying down soon after food can increase intragastric pressure. Reflux may involve acid, non-acid fluid or bile, so a standard antacid response is not always reliable.
A careful history should record the timing of symptoms, relation to meals, regurgitation, swallowing difficulty, vomiting, nocturnal symptoms and medication use. Alarm features such as progressive dysphagia, bleeding, iron-deficiency anaemia, persistent vomiting or unintentional weight loss require prompt specialist assessment.
Upper endoscopy can identify oesophagitis, Barrett’s oesophagus, ulcers, narrowing, retained food, sleeve twisting and a hiatus hernia. Biopsies may be needed when eosinophilic oesophagitis or another mucosal disorder is possible. A contrast swallow can show sleeve shape, delayed passage or reflux that is not obvious during endoscopy.
If endoscopy does not explain symptoms, ambulatory pH or pH-impedance monitoring can measure acid and non-acid reflux. High-resolution manometry assesses oesophageal movement and the lower sphincter before revision surgery. Testing should be selected by a gastroenterologist, particularly when symptoms persist despite a proton pump inhibitor.
A proton pump inhibitor (PPI) should usually be taken 30–60 minutes before the first meal, rather than at bedtime. If symptoms remain, a clinician may adjust the dose, split dosing or trial a different PPI after reviewing adherence and the diagnosis. An alginate preparation can provide short-term barrier relief, while an H2-receptor antagonist at night may be considered selectively because tolerance can develop.
Australian patients should check whether a prescribed medicine is PBS-listed, requires authority approval or involves a private cost. Over-the-counter products are widely available, but combining several acid medicines without medical advice can mask ongoing oesophageal injury. Long-term therapy should be reviewed in the context of kidney health, bone health, magnesium levels and other medicines.
Practical measures include smaller meals, slower eating, avoiding food for two to three hours before bed, raising the head of the bed and reducing individual triggers such as alcohol, fatty meals, chocolate or carbonated drinks. Smoking cessation and careful management of weight regain are valuable. These steps support medical treatment but should not delay investigation of anatomical problems.
Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass is the most established revisional operation for medically refractory reflux when testing confirms reflux or anatomy is unsuitable. It reduces acid exposure and diverts bile away from the oesophagus. A concurrent hiatus hernia repair may be required, although the final operation depends on endoscopy, imaging, symptoms, nutritional status and surgical risk.
Revisional surgery carries greater technical complexity than a primary procedure. Patients need discussion of anastomotic leaks, bleeding, strictures, internal hernia, marginal ulcer, nutritional deficiencies and the need for lifelong vitamin and mineral monitoring. In Australia, this assessment is best coordinated by a bariatric surgeon, gastroenterologist, dietitian and anaesthetic team with experience in revisional procedures.
Sleeve repair, hiatal repair alone or other anatomical revisions may suit selected patients, but they are not interchangeable with gastric bypass. Endoscopic therapies have a limited role after sleeve surgery and should be considered only in carefully selected circumstances and experienced centres.
A coordinated plan can make referrals and testing more efficient, especially when the patient lives outside a capital city. Telehealth may help with early gastroenterology or dietetic review, while endoscopy and imaging may still require travel to a regional hub or tertiary hospital. Public patients may face longer elective surgery waits; private treatment can offer earlier access but may involve substantial gaps beyond Medicare and insurance cover.
Patients should bring operative reports, previous endoscopy results, medication names and details of their original weight-loss journey. The treating team should also review nutritional blood tests, eating tolerance, pregnancy plans where relevant and any use of anti-inflammatory medicines.
Persistent symptoms deserve objective assessment rather than indefinite empiric treatment. For many suitable patients, conversion to Roux-en-Y gastric bypass offers effective reflux control, but the decision must follow anatomical and physiological testing. The key point is that ongoing reflux after sleeve gastrectomy is a treatable clinical problem when symptoms, sleeve anatomy and oesophageal function are assessed together.